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The quality of diabetes care delivered to patients falls
below the expectations of practice guidelines and
clinical trial evidence. Studies in many jurisdictions
with varying health care systems have shown that
recommended processes of care occur less often than
they should; hence, outcomes of care are inadequate.
Many studies comparing care between specialists and
generalists have found that specialists are more likely to
implement processes of care. However, this provides
little insight into improving quality of care, as the
difference between specialists and generalists in these
studies is small compared to the overall deficiency in
quality. Therefore, future research should instead focus
on ways to implement high quality care, regardless of
specialty. To date, few methodologically rigorous studies
have uncovered interventions that can improve quality
of care. The development of such interventions to help
all physicians implement better quality care could
greatly benefit people with diabetes.
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A
lthough many interventions have been shown to reduce
complications and improve health for people with diabe-
tes, both the use of these interventions and the achievement of
treatment targets are frequently below the expectations of
practice guidelines. These deficiencies in quality of care have
been documented all too frequently. In response, a growing
body of literature has examined whether specialists deliver
better quality care than generalists. Since the 1980s, when
just four were published, the number of papers published per
decade has risen 10-fold (Fig. 1). Most studies suggest that the
difference between specialists and generalists is small. In this
paper, we suggest that such studies are a distraction from the
more important issues of why diabetes care is suboptimal and
what can be done to improve diabetes management, regardless
of provider specialty.
OVERALL QUALITY OF CARE
Deficiencies in quality of diabetes care are found in many
countries with different health care systems for both process of
care measures (such as physical examination maneuvers and
the ordering of tests by physicians) and for outcomes of care
(the achievement of treatment targets and prevention of
complications). In a large study of American patients, fewer
than 20% received the recommended two A1c tests, one lipid
profile, and one dilated eye exam in 1 year.
1 Fewer than half of
patients surveyed in Italy reported receiving a foot exam over
1 year,
2 and only 11% of Canadian diabetic seniors with
established coronary artery disease were prescribed an anti-
platelet agent, a statin, and an angiotensin-converting enzyme
inhibitor.
3 At least partially as a result of these inadequate
processes of care, outcomes for patients are often poor. Data
from the 1990s using two U.S. health surveys found that 41%
of diabetic patients had A1c levels above 8.0%, and 18% had
levels over 9.5%. Only 42% of patients had LDL cholesterol
levels below 3.4 mmol/L and fewer than two thirds had blood
pressure levels below 140/90 mmHg.
4 Similar results have
been found in countries around the world.
5–8 The proportion of
patients meeting glycemic, blood pressure and cholesterol
targets did not differ between 1988–1994 and 1999–2000,
9
and although recent data suggest some small trends toward
improvement,
10 large numbers of patients remain inadequate-
ly treated.
DIFFERENCES IN QUALITY BETWEEN SPECIALIST
AND GENERALIST CARE
To address these gaps between evidence and practice, some
have speculated that specialists may deliver better chronic
disease care than generalists.
11 Although many investigators
have examined this question in diabetes, few studies
accounted for patient clustering within physicians and hence
JGIM
Received May 9, 2006
Revised September 27, 2006
Accepted October 9, 2006
Published online January 5, 2007
275statistical nonindependence. Those that did are summarized
below and in Table 1.
Processes of Care
A study in American ambulatory care clinics found that
patients with shared care between endocrinologists and gen-
eralists versus generalist-only care received more A1c and lipid
tests, and more dilated eye examinations.
1 Another smaller
study of 1,750 patients across the United States found
nonstatistically significant trends favoring specialists for many
processes of care.
12 An Italian group found that several
processes were more common for specialists’ patients com-
pared to general practitioners, including performance of self-
monitoring of blood glucose, foot examinations, A1c testing,
microalbuminuria testing, and dilated eye exams.
2,13,14 A
study using large Canadian administrative databases showed
that specialists escalated glucose-lowering medications for
patients with poor glycemic control more often than general-
ists,
15 and a Dutch study found that specialized diabetes
clinics measured patients’ blood pressures more often than
generalists did.
16 Thus, specialists often do provide better
processes of care than generalists, and yet in most cases, the
absolute difference is small compared to the deficiency that
even specialist care has compared to the ideal performance
level of 90% to 100% at which most of these processes ought to
be performed (see Table 1).
Outcomes of Care
Because differences between specialists and generalists for
many processes are small, it is not surprising that clinical
outcomes have not been shown to markedly differ between
them. In the Medical Outcomes Study, which prospectively
followed 424 diabetic patients in the 1980s, most clinical,
functional status and well-being measures did not differ
between physician groups; only foot ulcer prevalence showed
greater improvement for patients followed by endocrinologists,
but their patients had a higher prevalence at baseline.
17 The
Pittsburgh Epidemiology of Diabetes Complications Study
prospectively followed patients withtype 1diabetes for10years,
and showed that greater time under specialist care during
follow-up was associated with a reduced incidence of overt
nephropathy, but other micro- and macrovascular com-
plications were not different.
18 In Italy, despite small differences
in processes between specialists and general practitioners,
glycemic, blood pressure, and lipid control did not differ.
13,14
Canadian and German studies have also shown only small
differencesin glycemic control between specialist and generalist
care.
6,19 Specialist care did not significantly reduce the risk of
diabetes-related hospitalizations or emergency department
visits.
20
A REVISED FOCUS FOR STUDYING QUALITY OF CARE
These observations indicate that the magnitude of the differ-
ence between specialist and generalist care is inconsequential
compared to the magnitude of the overall deficiency in quality
of care. Therefore, research examining differences between
types of physicians is asking the wrong question; instead,
research should be identifying methods to improve quality of
care, regardless of the specialty of the providers.
The Cochrane Collaboration’s Effective Practice and Orga-
nisation of Care group has developed a conceptual framework
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Figure 1. An increasing number of studies have been published comparing specialist and generalist care for diabetes.
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Several groups have systematically reviewed trials of interven-
tions to improve quality of care, both in general,
21–25 and for
diabetes care in particular.
26,27 The interventions that have
been evaluated in diabetes care have included educational
materials and meetings, local consensus processes, educa-
tional outreach visits, audit and feedback programs, reminder
systems, changes to the health care team, formal case
management programs, and changes in record keeping and
communication between professionals. In addition, because
diabetes self-management requires the maintenance of a long-
term therapeutic alliance among patients, their family mem-
bers, and their health care providers,
28 successful quality
improvement interventions could target patients or their
families. Such interventions that have been evaluated include
individual- or group-based diabetes education programs deliv-
ered by various health professionals, telephone- and comput-
er-based education programs, and written educational
material for patients.
29–31 Notwithstanding the methodological
limitations of many of these trials, most interventions have
shown limited ability to change the delivery of care, and many
areas of the framework for change remain unstudied. Further-
more, educational interventions appear not to be additive:
Multiple interventions do not significantly change behavior
beyond what is achieved by a single intervention.
25 The
enormous gaps that remain in our ability to effectively change
the delivery of care underline an urgent need to devise
interventions to improve care and to test their effectiveness in
heterogeneous real-world populations by using pragmatic
trials.
32
However, developing such interventions will not be easy. In
1995, the Veterans Administration (VA) health care system was
reengineered by implementing more than 100 interventions to
improve quality of care, mostly organizational and educational
interventions.
33 When compared to the Medicare system,
many performance indicators (including annual measurement
of A1c and semiannual lipid screening for diabetic patients)
improved over the next several years.
34 However, many clinical
measures continued to have room for improvement; for
example, thousands of diabetic patients continued to miss
their annual retinal examinations. In decentralized health care
systems, such as those available to most patients in most
countries, it may be more difficult to apply the comprehensive
and resource-intensive interventions that the VA could imple-
ment, which would then attenuate any improvement in quality
of care that could be achieved. Nonetheless, a recent study did
show that halfway through a decade-long government and
professional initiative to improve quality of care in the United
Kingdom, some improvement in diabetes care was achieved.
35
The elusiveness of a “magic bullet” for practice improvement
and the systemic barriers to change in many settings should
not dissuade efforts to identify interventions, which will
produce small but important advances. From the framework
for changing practice (Fig. 2), educational interventions to
change physician and patient behavior have been studied to
some degree, although much more work needs to be done.
However, there is a genuine paucity of research examining
organizational, financial, and regulatory interventions that
change the environment in which care is delivered. Some
specific organizational changes that may help improve quality
of care include coordinated teams composed of multiple
professionals, where each element of care is delivered by the
provider with the greatest expertise and experience; informa-
tion technology to support communication and data transfer
within the team of providers and between the team and the
patient; and fostering the organizational culture of all stake-
holders (providers, institutions, payers, and regulators) to
encourage quality through system improvement.
36 Financial
interventions may include capitation, salary, or pay-for-
performance initiatives for primary care physicians,
37 while
regulatory interventions could include tying licensure to the
delivery of quality care.
Ultimately, interventions to improve ambulatory diabetes
management will have to meet several objectives to be
successful. They will have to be practicable so that they can
be implemented within busy clinical practices. Because diabe-
tes is so common, the interventions will need to be affordable
to ensure that they can be disseminated widely, and they will
have to be generalizable so that they can be used by physicians
with different practice styles in different regions and with
access to different resources. Finally, to ensure high uptake of
the interventions, they will likely need to include some
incentives to encourage physicians to use them.
Clinical research continues to find new and better ways of
treating diabetes and its complications to reduce the morbidity
and mortality for patients with the disease. But the efficacy
improvements of these new treatments could be matched by
relatively modest increases in the utilization of older, cheaper,
and less efficacious predecessor treatments among eligible
patients (see Fig. 3). While this calculation may be different
were the new treatments vastly more effective than their
predecessors, governments are choosing to invest resources
Table 1. A Selection of Studies Comparing Processes of Diabetes
Care Between Specialists and Generalists
Study Process measure Performance
rate by
specialists
(%)
Performance
rate by
generalists
(%)
Lafata
et al.
1
Measuring lipid
profile
77 70
Measuring A1c 84 58
Eye examination 51 33
All three 35 16
Greenfield
et al.
12
Measuring lipid
profile
45 51
Measuring urine
protein
58 42
Measuring A1c 90 79
Eye examination 41 34
Blood glucose self-
monitoring
83 73
De Berardis
et al.
14
Measuring total
cholesterol
66 66
Measuring
microalbuminuria
53 31
Measuring A1c 73 43
Eye examination 55 38
Foot examination 52 40
Shah
et al.
15
Drug escalation in
response to poor
glycemic control
45 37
Schaars
et al.
16
Measuring blood
pressure
73*
*Indicates the performance rate in the whole study population, as the
performance rate by group was not reported separately.
277 Shah et al.: Deficiencies in Quality of Diabetes Care JGIMPravastatin reduces CAD mortality by 24%. But, only 1/3 of eligible patients receive pravastatin.
IMPROVED DRUG EFFICACY
Rosuvastatin is 26% more effective than 
pravastatin for lowering lipid levels.
IMPROVED DRUG UTILIZATION
Intervention X increases utilization of pravastatin
from 4 in 12 eligible patients to 5 in 12.
If every patient currently taking pravastatin
were switched to rosuvastatin,
the additional population mortality reduction is
(0.24×1/3)×0.26 =
2%
If utilization of pravastatin by eligible patients
were increased by 1/12,
the additional population mortality reduction is
0.24×(1/12) =
2%
(Assumes a linear relationship between lipid levels and mortality) 
Figure 3. An example from Woolf et al.
38 to contrast the impact on population mortality of improving drug efficacy versus improving drug
utilization. In this example, developing a new drug, which requires billions of dollars of public and private sector investment, reduces mortality
to the same extent as a relatively modest improvement in the utilization of an existing drug might do.
EDUCATIONAL INTERVENTIONS 
￿   Distribution of educational materials 
￿   Educational meetings (e.g. lectures and 
workshops) 
￿   Local consensus processes 
￿   Educational outreach visits 
￿   Local opinion leaders 
￿   Patient mediated interventions 
￿   Audit and feedback 
￿   Reminders (including computerized 
decision support systems) 
￿   Marketing 
￿   Mass media 
FINANCIAL INTERVENTIONS 
￿ Provider-oriented 
￿ Capitation 
￿ Salaried  service 
￿ Formularies 
￿  Provider incentives or penalties 
￿  Institutional incentives or penalties 
￿ Patient-oriented 
￿ Premiums 
￿ Co-payments 
￿ User  fees 
￿  Patient incentives or penalties 
ORGANIZATIONAL INTERVENTIONS 
￿ Provider-oriented 
￿  Revision of professional roles 
￿ Multidisciplinary  teams 
￿ Skill  mix  changes 
￿  Continuity of care and case management
￿  Communication mechanisms (including 
telehealth) 
￿ Patient-oriented 
￿ Participation  in  governance 
￿ Structural 
￿  Physical structure and facilities 
￿ Medical  record  systems 
￿ Quality monitoring mechanisms 
REGULATORY INTERVENTIONS 
￿ Changes  in  medical  liability 
￿  Management of patient complaints 
￿ Peer  review 
￿ Licensure
IMPROVED
HEALTH
OUTCOMES
IMPROVED DELIVERY OF CARE
Figure 2. A conceptual framework for interventions to improve quality of care. Adapted from The Cochrane Collaboration’s Effective Practice
and Organisation of Care Group.
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278 Shah et al.: Deficiencies in Quality of Diabetes Care JGIMin a potentially less efficient way of improving health. The U.S.
Congress, for example, budgets just one penny for the Agency
for Healthcare Research and Quality to improve quality of care
for each dollar budgeted to the National Institutes of Health to
fund the development of new treatments, in addition to the
billions spent on drug development by the pharmaceutical
industry.
38 We argue in this paper that no magic bullet for
improving quality of care in diabetes has been found, and that
attention focused on specialist care is misplaced because of its
limited benefits and the financial and human resources
implications of increasing specialist care. However, the search
for the multiplicity of system and educational, professional,
and patient support strategies that will together achieve
improved quality surely warrants more investment than the
trifling amount it currently receives.
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